2021 亚太膝关节和髋关节置换及髋部骨折手术静脉血栓栓塞共识:静脉血栓栓塞的机械预防(第2部分)

2021-06-30 亚太地区骨科专家小组(统称) Knee Surg Relat Res.2021 Jun 30;33(1):20.

术后静脉血栓栓塞(VTE)是影响膝关节和髋关节置换及髋部骨折手术患者发病率和死亡率的主要因素。本文作为亚太地区膝关节和髋关节置换及髋部骨折手术静脉血栓栓塞共识的第2部分主要内容涉及静脉血栓栓塞的机械预

中文标题:

2021 亚太膝关节和髋关节置换及髋部骨折手术静脉血栓栓塞共识:静脉血栓栓塞的机械预防(第2部分)

英文标题:

Asia-Pacific venous thromboembolism consensus in knee and hip arthroplasty and hip fracture surgery: Part 2. Mechanical venous thromboembolism prophylaxis

发布日期:

2021-06-30

简要介绍:

术后静脉血栓栓塞(VTE)是影响膝关节和髋关节置换及髋部骨折手术患者发病率和死亡率的主要因素。本文作为亚太地区膝关节和髋关节置换及髋部骨折手术静脉血栓栓塞共识的第2部分主要内容涉及静脉血栓栓塞的机械预防。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 亚太膝关节和髋关节静脉血栓栓塞的机械预防(第2部分).pdf)] GetToolGuiderByIdResponse(projectId=1, id=5861b1c00212835f, title=2021 亚太膝关节和髋关节置换及髋部骨折手术静脉血栓栓塞共识:静脉血栓栓塞的机械预防(第2部分), enTitle=Asia-Pacific venous thromboembolism consensus in knee and hip arthroplasty and hip fracture surgery: Part 2. Mechanical venous thromboembolism prophylaxis, guiderFrom=Knee Surg Relat Res.2021 Jun 30;33(1):20., authorId=0, author=, summary=术后静脉血栓栓塞(VTE)是影响膝关节和髋关节置换及髋部骨折手术患者发病率和死亡率的主要因素。本文作为亚太地区膝关节和髋关节置换及髋部骨折手术静脉血栓栓塞共识的第2部分主要内容涉及静脉血栓栓塞的机械预, cover=https://img.medsci.cn/2021715/1626283043621_2020535.jpg, journalId=0, articlesId=null, associationId=1565, associationName=亚太地区骨科专家小组(统称), associationIntro=, copyright=0, guiderPublishedTime=Wed Jun 30 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p><span style="color: #373737;">术后静脉血栓栓塞(VTE)是影响膝关节和髋关节置换及髋部骨折手术患者发病率和死亡率的主要因素。本文作为亚太地区膝关节和髋关节置换及髋部骨折手术静脉血栓栓塞共识的第2部分主要内容涉及静脉血栓栓塞的机械预防。</span></p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=582, tagName=静脉血栓), TagDto(tagId=6964, tagName=髋关节置换)], categoryList=[CategoryDto(categoryId=10, categoryName=骨科, tenant=100), CategoryDto(categoryId=29, categoryName=麻醉疼痛科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=582, guiderKeyword=静脉血栓, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=8836, appHits=226, showAppHits=0, pcHits=509, showPcHits=8610, likes=0, shares=27, comments=18, approvalStatus=1, publishedTime=Thu Jul 15 01:51:49 CST 2021, publishedTimeString=2021-06-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Thu Jul 15 01:17:43 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Thu Jan 04 11:21:54 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 亚太膝关节和髋关节静脉血栓栓塞的机械预防(第2部分).pdf)])
2021 亚太膝关节和髋关节静脉血栓栓塞的机械预防(第2部分).pdf
下载请点击:
评论区 (14)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1214686, encodeId=0823121468679, content=***, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 19:27:45 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213358, encodeId=a25b1213358b6, content=英文版, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210822/2b6fa74f88c54ca79796ebdce7a184f0/e857af112e7a4d2d8625751e715b305d.jpg, createdBy=23475581308, createdName=掌心的雪花, createdTime=Fri Apr 22 08:40:09 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208999, encodeId=dbaf12089996f, content=英文的吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f91a5555640, createdName=ms5000000338064393, createdTime=Wed Apr 06 15:34:32 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206767, encodeId=0d771206e67e9, content=评论有积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f91a5555640, createdName=ms5000000338064393, createdTime=Tue Mar 29 01:45:24 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082000, encodeId=a370108200009, content=第一部分没有?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b6a1397021, createdName=xiaoping_xxp, createdTime=Mon Dec 20 09:28:49 CST 2021, time=2021-12-20, status=1, ipAttribution=)]
    2022-04-26 su_yi_fei

    ***

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1214686, encodeId=0823121468679, content=***, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 19:27:45 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213358, encodeId=a25b1213358b6, content=英文版, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210822/2b6fa74f88c54ca79796ebdce7a184f0/e857af112e7a4d2d8625751e715b305d.jpg, createdBy=23475581308, createdName=掌心的雪花, createdTime=Fri Apr 22 08:40:09 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208999, encodeId=dbaf12089996f, content=英文的吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f91a5555640, createdName=ms5000000338064393, createdTime=Wed Apr 06 15:34:32 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206767, encodeId=0d771206e67e9, content=评论有积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f91a5555640, createdName=ms5000000338064393, createdTime=Tue Mar 29 01:45:24 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082000, encodeId=a370108200009, content=第一部分没有?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b6a1397021, createdName=xiaoping_xxp, createdTime=Mon Dec 20 09:28:49 CST 2021, time=2021-12-20, status=1, ipAttribution=)]
    2022-04-22 掌心的雪花

    英文版

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1214686, encodeId=0823121468679, content=***, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 19:27:45 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213358, encodeId=a25b1213358b6, content=英文版, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210822/2b6fa74f88c54ca79796ebdce7a184f0/e857af112e7a4d2d8625751e715b305d.jpg, createdBy=23475581308, createdName=掌心的雪花, createdTime=Fri Apr 22 08:40:09 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208999, encodeId=dbaf12089996f, content=英文的吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f91a5555640, createdName=ms5000000338064393, createdTime=Wed Apr 06 15:34:32 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206767, encodeId=0d771206e67e9, content=评论有积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f91a5555640, createdName=ms5000000338064393, createdTime=Tue Mar 29 01:45:24 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082000, encodeId=a370108200009, content=第一部分没有?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b6a1397021, createdName=xiaoping_xxp, createdTime=Mon Dec 20 09:28:49 CST 2021, time=2021-12-20, status=1, ipAttribution=)]
    2022-04-06 ms5000000338064393

    英文的吗

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1214686, encodeId=0823121468679, content=***, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 19:27:45 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213358, encodeId=a25b1213358b6, content=英文版, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210822/2b6fa74f88c54ca79796ebdce7a184f0/e857af112e7a4d2d8625751e715b305d.jpg, createdBy=23475581308, createdName=掌心的雪花, createdTime=Fri Apr 22 08:40:09 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208999, encodeId=dbaf12089996f, content=英文的吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f91a5555640, createdName=ms5000000338064393, createdTime=Wed Apr 06 15:34:32 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206767, encodeId=0d771206e67e9, content=评论有积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f91a5555640, createdName=ms5000000338064393, createdTime=Tue Mar 29 01:45:24 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082000, encodeId=a370108200009, content=第一部分没有?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b6a1397021, createdName=xiaoping_xxp, createdTime=Mon Dec 20 09:28:49 CST 2021, time=2021-12-20, status=1, ipAttribution=)]
    2022-03-29 ms5000000338064393

    评论有积分

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1214686, encodeId=0823121468679, content=***, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 19:27:45 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213358, encodeId=a25b1213358b6, content=英文版, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210822/2b6fa74f88c54ca79796ebdce7a184f0/e857af112e7a4d2d8625751e715b305d.jpg, createdBy=23475581308, createdName=掌心的雪花, createdTime=Fri Apr 22 08:40:09 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208999, encodeId=dbaf12089996f, content=英文的吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f91a5555640, createdName=ms5000000338064393, createdTime=Wed Apr 06 15:34:32 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206767, encodeId=0d771206e67e9, content=评论有积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f91a5555640, createdName=ms5000000338064393, createdTime=Tue Mar 29 01:45:24 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082000, encodeId=a370108200009, content=第一部分没有?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b6a1397021, createdName=xiaoping_xxp, createdTime=Mon Dec 20 09:28:49 CST 2021, time=2021-12-20, status=1, ipAttribution=)]
    2021-12-20 xiaoping_xxp

    第一部分没有?

    0

拓展阅读

2014 ASCO 癌症患者静脉血栓栓塞防治指南(更新版)

美国临床肿瘤学会(ASCO,American Society of Clinical Oncology) · 2015-01-20

2015 ACFAS临床共识声明:需要进行固定的足踝部手术以及外伤静脉血栓血栓栓塞疾病的危险因素,预防和诊断

美国足踝外科医师协会(ACFAS,American College of Foot and Ankle Surgeons) · 2015-03-19

NCS:2015 预防神经重症监护患者静脉血栓指南

美国神经重症监护学会(NCS,Neurocritical Care Society) · 2015-05-14

2015 BCSH指南:肿瘤相关静脉血栓形成

英国血液学标准委员会(BCSH,British Committee for Standards in Haematology) · 2015-06-26

2016 妊娠相关静脉血栓栓塞症的诊断共识

国外妇产科相关专家组 · 2016-08-10